VIVO is intended for acquisition, analysis, display and storage of cardiac electrophysiological data and maps for analysis by a physician. VIVO is intended to be used as a pre-procedure planning tool for patients with structurally normal hearts undergoing ablation treatment for idiopathic ventricular arrhythmias. In clinical trials, VIVO was shown to be 100% (95% CI: 93.6%, 100% ) accurate in identifying a PVC or VT foci in the right, left, or septal region of the heart.


Alexander de Vries

Director Commercial Operations


There are no reviews yet.

Be the first to review “VIVO 2”

Your email address will not be published. Required fields are marked *